Contact Lens Spectrum

April 2007

Document #137

 

References

 

(p. 19) Contact Lens Materials: Fitting and Evaluating a Custom Silicone Hydrogel Lens, By Jones et al

 

1.         Senchyna M, et al.: Quantitative and conformational characterization of lysozyme deposited on balafilcon and etafilcon contact lens materials. Curr Eye Res 2004  28;1: 25-36.

2.         Subbaraman LN, et al.: Rewetting drops containing surface active agents improve the clinical performance of silicone hydrogel contact lenses. Optom Vis Sci 2006  83;3: 143-51.

3.         Subbaraman LN, et al.: Kinetics of in vitro lysozyme deposition on silicone hydrogel, PMMA, and FDA groups I, II, and IV contact lens materials. Curr Eye Res 2006  31;10: 787-96.

4.         Maziarz EP, et al.: Lipid deposition on silicone hydrogel lenses, part I: quantification of oleic Acid, oleic Acid methyl ester, and cholesterol. Eye Contact Lens 2006  32;6: 300-7.

5.         Dumbleton KA, et al.: Changes in myopic refractive error with nine months' extended wear of hydrogel lenses with high and low oxygen permeability. Optom Vis Sci 1999  76;12: 845 - 849.

6.         Jalbert I, et al.: Changes in myopia with low-Dk hydrogel and high-Dk silicone hydrogel extended wear. Optom Vis Sci 2004  81;8: 591-6.

7.         Keay L, et al.: Microcyst response to high Dk/t silicone hydrogel contact lenses. Optom Vis Sci 2000  77;11: 582 - 585.

8.         Dumbleton KA, et al.: Vascular response to extended wear of hydrogel lenses with high and low oxygen permeability. Optom Vis Sci 2001  78;3: 147 - 151.

9.         Dumbleton K, et al.: Objective and subjective responses in patients refitted to daily-wear silicone hydrogel contact lenses. Optom Vis Sci 2006  83;10: 758-68.

10.       Jones L, MacDougall N, Sorbara LG: Asymptomatic corneal staining associated with the use of balafilcon silicone-hydrogel contact lenses disinfected with a polyaminopropyl biguanide-preserved care regimen. Optom Vis Sci 2002  79;12: 753 - 761.

11.       Garofalo RJ, et al.: Corneal staining and subjective symptoms with multipurpose solutions as a function of time. Eye Contact Lens 2005  31;4: 166 - 174.

 

 

(p. 23) Dry Eye Dx and Tx: Is it Possible to Achieve Consensus in Dry Eye? By Kelly Nichols, OD, MPH, PhD

 

  1. Lemp MA. Report of the National Eye Institute/ Industry workshop on clinical trials in dry eye. CLAO J 1995; 21:221-32.
  2. Behrens et al. Dysfunctional tear syndrome. Cornea, 2006 25(8):900-7.
  3. Baum J et al. What's in a name? Cornea, 2006 25(8):871-2.

 

 

 

(p. 22) Treating Allergy in Contact Lens Patients, by John L. Schachet, OD

 

1.      Schoenwetter WF, Dupclay L Jr., Appajoysyula S, Botteman MF, Pashos CL.       Economic impact and quality-of-life burden of allergic rhinitis.  Curr Med Res Opin. 2004 Mar; 20(3):305-317.

2.      Berger W, Abelson MB, GomesPJ, et al.  Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy.  Ann Allergy Asthma Immunol. 2005 Oct; 95(4):361-371.

3.      Dykewicz M, Fineman S, Skoner DP et al.  Diagnosis and management of rhinitis: complete guidelines of the joint task force on practice parameters in allergy, asthma and immunology.  Ann Allergy Asthma Immunol. 1998; 81:478-518.

4.      Solomon, HR. Managing nonnasal symptoms of allergic rhinitis.  Notes from American College of Allergy, Asthma and Immunology, 2006 Annual Meeting.  Medscape.com; Jan. 2007.

5.      DeWester J, Philpot EE, Westlund RE, et al.  The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis.  Allergy Asthma Proc. 2003; 24:331-337.

 

 

(p. 32) Proactively Prevent Contact Lens Dropout, By Susan Kovacich, OD, FAAO

 

1. Barr JT. Contact Lenses 2005. Contact Lens Spectrum 21(1): 26-34, 2006

2. Pritchard N, Fonn D, Brazeau D : Discontinuation of Contact Lens Wear : A Survey. International Contact Lens Clinic 26 (6): 157-162, 1999

3. Caffery B et al. Dry Eye: A Common and Complicated Problem. Contact Lens Spectrum 12(5): 41-47, 1997

4. Andrasko GJ, Ryen KA, Garofalo RJ, Lemp JM. Compatibility of Silicone Hydrogel Lenses With Multi-Purpose Solutions. Poster presented at ARVO 2006, Ft. Lauderdale, Fla.

5. Miller WL. Medication Effects on the Anterior Segment and Contact Lens Wear. Contact Lens Spectrum 18(9): 22-28, 2003

6. Morgan PB, Efron N: In vivo dehydration characteristics of silicone hydrogel contact lenses. Eye and Contact Lenses 29(3): 173-176, 2003

7. Hom MM. Use of Cyclosporine 0.05% Ophthalmic Emulsion for Contact Lens-Intolerant Patients. Eye and Contact Lens 32(2):109-111, 2006

 

 

(p. 36) Deciphering Corneal Staining Scales, By Lynn Lasswell, OD, Stan Huth, MA, & Denise Tran, BS

 

1.Wolffsohn JS. Incremental nature of anterior eye grading scales determined by objective image analysis. Br J Ophthalmol 2004;88:1434-8.

2.[1]              Begley CG, Barr JT, Edrington TB, et al. Characteristics of corneal staining in hydrogel lens wear. Optom Vis Sci 1996;73:193-200

3.[1] Efron N, Morgan PB, Katsara SS. Validation of grading scales for contact lens complications. Ophthalmic Physiol Opt 2001;21:17-29.

4.[1] Terry RL, Schnider CM, Holden BA, et al. CCLRU standards for success of daily and extended wear contact lenses. Optom Vis Sci 1993;70(3):2343.

5.[1] Jones L, MacDougall N, Sorbara LG. Asymptomatic corneal staining associated with the use of balafilcon silicone-hydrogel contact lenses disinfected with a polyaminopropyl biguanide-preserved care regimen. Optom Vis Sci 2002;79:753-61.

6.[1] Woods J, Woods C, Varikooty J, et al. A novel method for recording corneal staining that facilitates parametric analysis. Presented at the American Academy of Optometry, December 8, 2006.

7.[1] Andrasko GJ, Ryen KA, Garofalo RJ, Lemp JM. Compatibility of silicone hydrogel lenses with multi-purpose solutions. Presented as a poster at the Association for Research in Vision and Ophthalmology (ARVO) meeting, 2006.

8.[1] Andrasko GJ, Ryen KA, Garofalo RJ, Lemp JM. Ocular response observed with silicone hydrogel lenses and multi-purpose solution combinations. Presented as a poster at the American Optometric Association (AOA) meeting, 2006. Available at: http://www.staininggrid.com/docs/AOA_Poster_2006_Andrasko.pdf Accessed Nov 3, 2006

9.[1] Andrasko G. Evaluation of corneal staining with various contact lens/solution combinations. Clinical Trials. National Institutes of Health. Available at: www.clinicaltrials.gov/ct/gui/show/NCT00381446;jsessionid Accessed Nov. 3, 2006

10.  [1]           The Staining Grid Center, Contact Lens Research Services, www.staininggrid.com  Accessed Nov 3, Nov 5, and Nov 12, 2006

11.  [1]           Data on file, Advanced Medical Optics, Inc.

12.  [1]           EyeMatters Newsletter, Bausch & Lomb, Inc., August 2006  www.eyematters.com/newsletter.asp?id=7 and www.eyematters.com/newsletter.asp?id=78    

13.  [1]           Amos C. Performance of a new multipurpose solution used with silicone hydrogels. 02 April 2004. www.Opticianonline.net/Articles/Article.aspx?liArticleID=4751

14.  [1]           Schwallie J, McKenney C, Long B, McNeil A. Corneal staining patterns in normal non-contact lens wearers. Ophthal Physiol Opt 2001;21:30-5

15.  [1]           Dundas M, Walker A, Woods RL. Clinical grading of corneal staining of non-contact lens wearers. Ophthal Physiol Opt 2001;21(1):30-5.

16.  [1]           Begley CG, Barr JT, Edrington TB, et al. Characteristics of corneal staining in hydrogel lens wear. Optom Vis Sci 1996;73:193-200

17.  [1]           Nichols KK, Mitchell GL, Simon KM, et al. Corneal staining in hydrogel lens wearers. Optom Vis Sci 2002;79(1):20-30.

18.  [1]           Josephson JE, Caffery BE. Corneal staining after instillation of topical anesthetic (SSII). Invest Ophthalmol Vis Sci 1988;29:1096-9

19.  [1]           Jalbert I, Carnt N, Stretton S, et al. Solution toxicity in soft contact lens daily wear is associated with corneal inflammation. Presented as a poster at the Association for Research in Vision and Ophthalmology (ARVO) 2006. Available at: http://www.staininggrid.com/docs/ARVO2006poster_Papas_Staining_Infiltrates.pdf

  1. [1]           Santodomingo-Rubido J, Wolffsohn JS, Gilmartin B. Changes in ocular physiology, tear film characteristics, and symptomatology with 18 months silicone hydrogel contact lens wear. Optom Vis Sci 2006;83(2):73-81.

 

 

(p. 41) Testing MPS Lens Care Solutions Against Staphylococcus aureus, By S. F. Groemminger & Susan Norton

 

  1. The bacterial flora of the healthy eye. In: Locatcher-Khorazo D, Seegal B, ed. Microbiology of the Eye. St. Louis: C.V. Mosby CO; 1972:13-23.

 

  1. Alexandrakis G, Alfonso E, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology. 2000; 107:1497-1502.

 

  1. de Andrade Sobrinho M, Carvalho R. Do the economic and social factors play an important role in relation to the compliance of contact lenses care routines? Eye Contact Lens. 2003; 29:210-212.

 

  1. Khor W-B, Aung T, Saw S-M, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA. 2006; 295:2867-2873.

 

  1. Rosenthal R, McAnally C, McNamee L, et al. Broad spectrum antimicrobial activity of a new multi-purpose disinfecting solution. CLAO J. 2000; 26:120-126.

 

  1. Rosenthal R, Sutton S, Schlech B. Review of standard for evaluating the effectiveness of contact lens disinfectants. PDA J Pharm Sci Technol. 2002; 56:37-50.

 

  1. Silbert J. Microbial disease and the contact lens patient. Int Contact Lens Clin. 1988; 15:221-228.

 

  1. Sven E, Montan P. The hospitalized cases of contact lens induced keratitis in Sweden and their relation to lens type and wear schedule: results of a three year retrospective study. CLAO J. 1994; 20:97-101.

 

  1. Tabbara K, Antonios S, Alvarez H. Effects of fusidic acid on staphylococcal keratitis. Br J Ophthalmol. 1989; 73:136-139.

 

 

(p. 44) The Contact Lens Exam: Determining Posterior Elevation, By Loretta Szczotka-Flynn, OD, MS, FAAO

 

  1. Wei R, Lim L, Chan W, Tan D. Evaluation of Orbscan II Corneal Topography in Individuals with Myopia. Ophthalmology 2006; 113:117-183.

 

  1. Rao S, Raviv T, Majmudar P, Epstein R. Role of Orbscan II in screening Keratoconus Suspects before refractive surgery. Ophthalmology 2002; 109:1642-1646.

 

 

(p. 47) Treatment Plan: Preventing the Destruction of Endophthalmitis, By William L. Miller, OD, PhD, FAAO

 

  1. Majid Moshirfar, MD, FACS, Vahid Feiz, MD, Albert T. Vitale, MD, Jacob A. Wegelin, PhD,Screenivasa Basavanthappa, MD, Darcey H. Wolsey, MD Endophthalmitis after Uncomplicated Cataract Surgery with the Use of Fourth-Generation Fluoroquinolones A Retrospective Observational Case Series. Ophthalmology 2007;114:686-691

 

  1. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group* Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration. Two-Year Safety Results of the Two Prospective, Multicenter, Controlled Clinical Trials. Ophthalmology 2006;113:992-1001

 

 

(p. 50) Readers’ Forum: Lens-assisted Pharmacological-induced Kerato-steepening, By Earle Scharff, OD

 

Jay McDonald, MD et al. …CLAPIKS Offers Novel Pharmacological Approach for Treatment of the Hyperopia After LASIK Surgery,  http://www.escrs.org/eurotimes/june2003/CLAPIKS.asp